JPI Healthcare Co.,Ltd. (KOSDAQ:0010V0)
South Korea · Delayed Price · Currency is KRW 8,760.00
-400.00 (-4.37%)
At close: May 29, 2026
JPI Healthcare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Operating Revenue | 47,967 | 48,467 | 45,053 | 45,412 |
Other Revenue | -0 | - | -0 | -0 |
| 47,967 | 48,467 | 45,053 | 45,412 | |
Revenue Growth (YoY) | 5.83% | 7.58% | -0.79% | - |
Cost of Revenue | 28,905 | 28,601 | 25,508 | 26,623 |
Gross Profit | 19,062 | 19,866 | 19,545 | 18,789 |
Selling, General & Admin | 10,672 | 10,513 | 11,031 | 9,198 |
Research & Development | 3,581 | 3,582 | 3,839 | 3,093 |
Amortization of Goodwill & Intangibles | 114.62 | 97.04 | 93.03 | 80.57 |
Other Operating Expenses | 225.48 | 231.68 | 216.99 | 198.4 |
Operating Expenses | 15,199 | 15,006 | 15,607 | 12,219 |
Operating Income | 3,863 | 4,859 | 3,938 | 6,570 |
Interest Expense | -359.24 | -406.92 | -403.47 | -326.11 |
Interest & Investment Income | 582.59 | 448.6 | 355.53 | 166.96 |
Currency Exchange Gain (Loss) | 545.14 | -342.25 | 683.57 | 263.56 |
Other Non Operating Income (Expenses) | 493.68 | 398.98 | 1,023 | 19.6 |
EBT Excluding Unusual Items | 5,125 | 4,958 | 5,597 | 6,694 |
Gain (Loss) on Sale of Investments | 580.08 | 680.08 | 922.99 | 844.07 |
Gain (Loss) on Sale of Assets | 15.91 | 0.3 | -2.91 | -54.9 |
Pretax Income | 5,721 | 5,638 | 6,517 | 7,483 |
Income Tax Expense | 688.86 | 795.92 | 964.83 | 1,144 |
Earnings From Continuing Operations | 5,032 | 4,842 | 5,553 | 6,339 |
Minority Interest in Earnings | 433.51 | 415.99 | 483.47 | 268.96 |
Net Income | 5,466 | 5,258 | 6,036 | 6,608 |
Preferred Dividends & Other Adjustments | - | - | 1,101 | 720.3 |
Net Income to Common | 5,466 | 5,258 | 4,935 | 5,888 |
Net Income Growth | -11.78% | -12.88% | -8.66% | - |
Shares Outstanding (Basic) | 5 | 4 | 2 | 2 |
Shares Outstanding (Diluted) | 5 | 5 | 4 | 4 |
Shares Change (YoY) | 14.12% | 8.30% | - | - |
EPS (Basic) | 1151.60 | 1232.48 | 2350.00 | 2803.68 |
EPS (Diluted) | 1151.60 | 1168.00 | 1451.66 | 1589.23 |
EPS Growth | -22.70% | -19.54% | -8.66% | - |
Free Cash Flow | 2,711 | 2,086 | -6,982 | 3,710 |
Free Cash Flow Per Share | 571.26 | 463.20 | -1679.24 | 892.14 |
Dividend Per Share | 250.000 | 250.000 | - | 350.000 |
Gross Margin | 39.74% | 40.99% | 43.38% | 41.38% |
Operating Margin | 8.05% | 10.03% | 8.74% | 14.47% |
Profit Margin | 11.39% | 10.85% | 10.95% | 12.96% |
Free Cash Flow Margin | 5.65% | 4.30% | -15.50% | 8.17% |
EBITDA | 5,431 | 6,384 | 5,532 | 8,132 |
EBITDA Margin | 11.32% | 13.17% | 12.28% | 17.91% |
D&A For EBITDA | 1,569 | 1,525 | 1,594 | 1,562 |
EBIT | 3,863 | 4,859 | 3,938 | 6,570 |
EBIT Margin | 8.05% | 10.03% | 8.74% | 14.47% |
Effective Tax Rate | 12.04% | 14.12% | 14.80% | 15.29% |
Advertising Expenses | - | 1,007 | 1,083 | 921.85 |